Iterum Therapeutics Plc Overview
Iterum Therapeutics Plc Discounted Cash Flow
DCF Analysis for ITRM.
Get informed when a big investor buys or sells
+ FollowFair Value
$-1.09
Current Fair Value
$-1.09
↓ 3722.7% Downside
Overvalued by 3722.7% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison